Endeva raises $311M for natural AI drug clinical trials

In a funding round, the company’s valuation reached $2 billion, and it is currently conducting clinical trials for a skin disease treatment and a GLP-1–based weight-management drug.

Why it mattersAn important trend showing the scale of funding for AI-enabled drug discovery ventures and accelerated clinical development.